HC Wainwright Lowers Arcus Biosciences (NYSE:RCUS) Price Target to $18.00
Arcus Biosciences (NYSE:RCUS – Get Free Report) had its price target dropped by equities researchers at HC Wainwright from $20.00 to $18.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. HC Wainwright’s target price indicates a potential upside of 62.38% from the stock’s current price. […]
Arcus Biosciences (NYSE:RCUS – Get Free Report) had its price target dropped by equities researchers at HC Wainwright from $20.00 to $18.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. HC Wainwright’s target price indicates a potential upside of 62.38% from the stock’s current price. […]
